Reference change values

被引:223
作者
Fraser, Callum G. [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Res Canc Prevent & Screening, Dundee DD1 9SY, Scotland
关键词
biological variation; imprecision; probability; reference change values; BIOLOGICAL VARIATION; DIAGNOSIS; QUALITY;
D O I
10.1515/CCLM.2011.733
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Reference change values (RCV) provide objective tools for assessment of the significance of differences in serial results from an individual. The concept is simple and the calculation easy, since all laboratories know their analytical imprecision (CVA) and estimates of within-subject biological variation (CVI) are available for a large number of quantities. Generally, CVI are constant over time, geography, methodology and in health and chronic stable disease. The formula is RCV = 2(1/2) . Z . (CVA2 + CVI2)(1/2), where Z is the number of standard deviations appropriate to the probability. Correct interpretation of the semantics describing the clinical use of RCV is vital for selection of the Z-score. Many quantities of clinically importance exist for which good estimates of RCV are unavailable. Derivation of CVI may be difficult for such quantities: flair and imagination are required in selecting populations with chronic but stable disease on whom CVI can be determined. RCV can be used for delta-checking and auto-verification and laboratory information management systems (LIMS) can be adapted to do this. Recently, log-normal transformation to obtain unidirectional RCV has been used. Gaps in knowledge of RCV still require filling since the need for measures of change is clearly expressed in guidelines.
引用
收藏
页码:807 / 812
页数:6
相关论文
共 30 条
[1]  
[Anonymous], 2001, Biological variation: from principles to practice
[2]  
[Anonymous], 2008, DEF EST VER REF INT
[3]  
[Anonymous], BIOL VARIATION DATAB
[4]  
[Anonymous], INTERPRETATION DIFFE
[5]   Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events [J].
Apple, Fred S. ;
Pearce, Lesly A. ;
Smith, Stephen W. ;
Kaczmarek, Jason M. ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2009, 55 (05) :930-937
[6]   The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing [J].
Cembrowski, George S. ;
Tran, David V. ;
Higgins, Trefor N. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (10) :1447-1454
[7]   Reference change values for monitoring dehydration [J].
Cheuvront, Samuel N. ;
Fraser, Callum G. ;
Kenefick, Robert W. ;
Ely, Brett R. ;
Sawka, Michael N. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (06) :1033-1037
[8]   Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality [J].
Cooper, Greg ;
DeJonge, Niels ;
Ehrmeyer, Sharon ;
Yundt-Pacheco, John ;
Jansen, Rob ;
Ricos, Carmen ;
Plebani, Mario .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) :793-802
[9]   Biological variation of glycated haemoglobin in a paediatric population and its application to calculation of significant change between results [J].
Desmeules, Philippe ;
Cousineau, Jocelyne ;
Allard, Pierre .
ANNALS OF CLINICAL BIOCHEMISTRY, 2010, 47 :35-38
[10]   International uniform response criteria for multiple myeloma [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2006, 20 (09) :1467-1473